Cargando…

Landiolol for managing atrial fibrillation in post-cardiac surgery

Landiolol is an intravenous ultra-short acting beta-blocker which has been used in Japan for many years to prevent and/or to treat post-operative atrial fibrillation following cardiac surgery. The drug is now available in Europe. This article is a systematic review of literature regarding the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fellahi, Jean-Luc, Heringlake, Matthias, Knotzer, Johann, Fornier, William, Cazenave, Laure, Guarracino, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909770/
https://www.ncbi.nlm.nih.gov/pubmed/30188961
http://dx.doi.org/10.1093/eurheartj/sux038
_version_ 1783315954840633344
author Fellahi, Jean-Luc
Heringlake, Matthias
Knotzer, Johann
Fornier, William
Cazenave, Laure
Guarracino, Fabio
author_facet Fellahi, Jean-Luc
Heringlake, Matthias
Knotzer, Johann
Fornier, William
Cazenave, Laure
Guarracino, Fabio
author_sort Fellahi, Jean-Luc
collection PubMed
description Landiolol is an intravenous ultra-short acting beta-blocker which has been used in Japan for many years to prevent and/or to treat post-operative atrial fibrillation following cardiac surgery. The drug is now available in Europe. This article is a systematic review of literature regarding the use of landiolol in that specific surgical setting.
format Online
Article
Text
id pubmed-5909770
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-59097702018-04-24 Landiolol for managing atrial fibrillation in post-cardiac surgery Fellahi, Jean-Luc Heringlake, Matthias Knotzer, Johann Fornier, William Cazenave, Laure Guarracino, Fabio Eur Heart J Suppl Articles Landiolol is an intravenous ultra-short acting beta-blocker which has been used in Japan for many years to prevent and/or to treat post-operative atrial fibrillation following cardiac surgery. The drug is now available in Europe. This article is a systematic review of literature regarding the use of landiolol in that specific surgical setting. Oxford University Press 2018-01 2018-01-08 /pmc/articles/PMC5909770/ /pubmed/30188961 http://dx.doi.org/10.1093/eurheartj/sux038 Text en Published on behalf of the European Society of Cardiology. © The Author 2018. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Articles
Fellahi, Jean-Luc
Heringlake, Matthias
Knotzer, Johann
Fornier, William
Cazenave, Laure
Guarracino, Fabio
Landiolol for managing atrial fibrillation in post-cardiac surgery
title Landiolol for managing atrial fibrillation in post-cardiac surgery
title_full Landiolol for managing atrial fibrillation in post-cardiac surgery
title_fullStr Landiolol for managing atrial fibrillation in post-cardiac surgery
title_full_unstemmed Landiolol for managing atrial fibrillation in post-cardiac surgery
title_short Landiolol for managing atrial fibrillation in post-cardiac surgery
title_sort landiolol for managing atrial fibrillation in post-cardiac surgery
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909770/
https://www.ncbi.nlm.nih.gov/pubmed/30188961
http://dx.doi.org/10.1093/eurheartj/sux038
work_keys_str_mv AT fellahijeanluc landiololformanagingatrialfibrillationinpostcardiacsurgery
AT heringlakematthias landiololformanagingatrialfibrillationinpostcardiacsurgery
AT knotzerjohann landiololformanagingatrialfibrillationinpostcardiacsurgery
AT fornierwilliam landiololformanagingatrialfibrillationinpostcardiacsurgery
AT cazenavelaure landiololformanagingatrialfibrillationinpostcardiacsurgery
AT guarracinofabio landiololformanagingatrialfibrillationinpostcardiacsurgery